Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dosing recommendations for pharmacogenetic interactions related to drug metabolism.

Pharmacogenetics and genomics - 1 Jul 2016

Filipski Kelly K, Pacanowski Michael A, Ramamoorthy Anuradha, Feero William Gregory, Freedman Andrew N

Abstract excerpt

OBJECTIVE: Pharmacogenomic studies have established the important contribution of drug-metabolizing enzyme genotype toward drug toxicity and treatment failure; however, clinical implementation of pharmacogenomics has been slow. The aim of this study was to systematically review the information on drug-metabolizing enzyme pharmacogenomics available in the US drug labeling, practice guidelines, and recommendations....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Drug Monitoring

Share to Drug-Related Side Effects and Adverse Reactions

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Share to Practice Guidelines as Topic

Source

Identifiers

PMID: 27058883
DOI: 10.1097/FPC.0000000000000220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dosing recommendations for pharmacogenetic interactions related to drug metabolism.PMID 27058883Read ↗

Clinically relevant genetic variations in drug metabolizing enzymes.Semantic proximity Read ↗

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical PracticeSemantic proximity Read ↗

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effectsSemantic proximity Read ↗

Pharmacogenetics: from discovery to patient care.Semantic proximity Read ↗

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Semantic proximity Read ↗

Impact of pharmacogenomics on the clinical laboratory.Semantic proximity Read ↗

Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Adding pharmacogenetics information to drug labels: lessons learned.Semantic proximity Read ↗

Pharmacogenetics and drug metabolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.